Life Sciences Virtual Investor Forum Connects Companies with Global Investors Through Digital Platform

The Life Sciences Virtual Investor Forum, taking place March 11 and 12, 2026, serves as a critical digital platform connecting public life sciences companies with a global audience of individual and institutional investors. This event, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, enables presenting companies to deliver scheduled live presentations followed by real-time Q&A sessions, with investors able to request one-on-one meetings with management teams through the VIC platform. The forum's importance lies in its ability to bridge the gap between innovative life sciences firms seeking capital and investors looking for opportunities across a broad range of therapeutic and healthcare markets, from neurology to oncology and medical devices.

Participating companies include SeaStar Medical Holding Corporation, Nasus Pharma Ltd., Tonix Pharmaceuticals Holding Corp., and Jupiter Neurosciences, Inc. on March 11, with March 12 featuring Bora Pharmaceuticals, Prostatype Genomics AB, MetaVia Inc., Phio Pharmaceuticals Corp., Avicanna Inc., EMVision Medical Devices Ltd., Aethlon Medical, Dyadic International, Jaguar Health, Inc., Beyond Air, Inc., Cadrenal Therapeutics, Inc., and Amplia Therapeutics Ltd. Among these, Jupiter Neurosciences, Inc. and Phio Pharmaceuticals Corp. are highlighted as B2i Digital Featured Companies. The event structure allows for extended visibility, as presentation replays become available for on-demand viewing after the live sessions, ensuring ongoing engagement beyond the initial broadcast.

B2i Digital, Inc. partners with Virtual Investor Conferences as the Official Marketing Partner, supporting awareness through digital marketing, social media promotion, digital profiles of presenting companies, and broader investor outreach. This collaboration amplifies the forum's reach within the investment community. For comprehensive profiles of participating companies and registration details, investors can visit the Virtual Investor Conferences platform. Additional information about the event is available at the B2i Digital website.

The implications of this virtual forum are significant for the life sciences sector, as it provides an efficient, scalable way for companies to showcase their innovations and business strategies directly to potential investors without geographical constraints. In an industry where research and development require substantial funding, such platforms democratize access to investment opportunities, allowing smaller or emerging companies to gain visibility alongside more established firms. Virtual Investor Conferences, as an OTC Markets Group Inc. property, hosts companies listed on major exchanges including NYSE, Nasdaq, TSX, CSE, ASX, and OTC Markets, ensuring a diverse participant base. This event underscores the growing trend toward digital solutions in capital markets, facilitating meaningful connections that can drive funding for advancements in healthcare and therapeutics.